Interpreting Bristol-Myers : Are Unnamed Members of Nationwide Class Actions ‘Parties’? If So, When?
In 2017, the Supreme Court decided Bristol-Myers Squibb Co. v. Superior Court of California (BMS), holding that a...more
8/11/2020
/ Article III ,
Bristol-Myers Squibb Co v Superior Court of California - San Francisco County ,
Class Action ,
Class Certification ,
Class Members ,
Class Representatives ,
Direct Purchasers ,
Discovery ,
Due Process ,
Forum Selection ,
FRCP 23 ,
FRCP 26(b)(1) ,
Mass Tort Litigation ,
Multidistrict Litigation ,
Out-of-State Residents ,
Personal Jurisdiction ,
Putative Class Actions ,
Ripeness ,
SCOTUS ,
Split of Authority ,
Standing ,
Subject Matter Jurisdiction ,
Substantially Similar ,
Vacated ,
Venue ,
Writ of Mandamus
Several pending rulings at the circuit court level have the potential to significantly influence class action law in 2020. Of greatest note, the U.S. Court of Appeals for the Sixth Circuit may determine the future of...more
1/27/2020
/ All Natural ,
Appeals ,
Bristol-Myers Squibb Co v Superior Court of California - San Francisco County ,
Class Action ,
Class Certification ,
Consumer Fraud ,
Corporate Counsel ,
Deceptively Misdescriptive ,
False Advertising ,
FRCP 23 ,
Labeling ,
Multidistrict Litigation ,
Non-Residents ,
Out-of-State Residents ,
Pending Litigation ,
Personal Jurisdiction ,
Rules Enabling Act ,
Settlement Negotiations
Multidistrict litigation (MDL) proceedings comprise a large and growing portion of the federal civil docket. According to Lawyers for Civil Justice, an association of defense counsel, MDLs encompassed 52% of all federal civil...more
In 2019, significant developments are expected on issues that have been percolating in the mass tort and class action litigation arena for several years. The U.S. Supreme Court is expected to rule on cases relating to...more
1/24/2019
/ Arbitration ,
Asbestos Litigation ,
Class Action ,
Class Arbitration ,
Clear Evidence Standard ,
Consumer Protection Laws ,
Cy Pres Funds ,
Failure To Warn ,
Food and Drug Administration (FDA) ,
Forum State ,
In re Google Referrer Header Privacy Litigation ,
Lamps Plus Inc v Varela ,
Mass Tort Litigation ,
Merck Sharp & Dohme Corp. v. Albrecht ,
Multidistrict Litigation ,
Personal Jurisdiction ,
Pharmaceutical Industry ,
Preemption ,
Product Defects ,
Proposed Legislation ,
SCOTUS ,
Solicitor General ,
The Fairness in Class Action Litigation Act of 2015 ,
Warning Labels
In 2016, the U.S. Supreme Court is expected to hand down several decisions addressing overbroad or “no-injury” class actions, and a number of important issues are percolating in the lower courts as well. Below are some issues...more
1/22/2016
/ Article III ,
Ascertainable Class ,
Class Action ,
Class Certification ,
Corporate Counsel ,
Cy Pres Funds ,
Due Process ,
FRCP 23 ,
Litigation Funding ,
Mass Tort Litigation ,
Multidistrict Litigation ,
SCOTUS ,
Standing ,
Third-Party Relationships ,
Tyson Foods v Bouaphakeo ,
Young Lawyers